Lejeune C, Bourredjem A, Binquet C, Cussenot O, Boudrant G, Papillon F, Bruyère F, Haillot O, Koutlidis N, Bassard S, Fournier G, Valeri A, Moreau JL, Pierfitte B, Moulin M, Berchi C, Cormier L

World J Urol. 2023 05 12;:

Cost of exome analysis in patients with intellectual disability: a micro-costing study in a French setting.

Soilly AL, Robert-Viard C, Besse C, Bruel AL, Gerard B, Boland A, Piton A, Duffourd Y, Muller J, Poë C, Jouan T, El Doueiri S, Faivre L, Bacq-Daian D, Isidor B, Genevieve D, Odent S, Philip N, Doco-Fenzy M, Lacombe D, Asensio ML, Deleuze JF, Binquet C, , Thauvin-Robinet C, Lejeune C

BMC Health Serv Res. 2023 04 21;23(1):386

The place of general practitioner in the management of patients with rare disease and intellectual disability: A qualitative study.

Roux-Levy PH, Perrard Y, Mazalovic K, Zabawa C, Meunier-Beillard N, Binquet C, Lejeune C, Faivre L

Eur J Med Genet. 2022 08 30;:104604

The Economic, Medical and Psychosocial Consequences of Whole Genome Sequencing for the Genetic Diagnosis of Patients With Intellectual Disability: The DEFIDIAG Study Protocol.

Lejeune C, Robert-Viard C, Meunier-Beillard N, Borel MA, Gourvès L, Staraci S, Soilly AL, Guillemin F, Seror V, Achit H, Bouctot M, Asensio ML, Briffaut AS, Delmas C, Bruel AL, Benoit A, Simon A, Gerard B, Hadj Abdallah H, Lyonnet S, Faivre L, Thauvin-Robinet C, Odent S, Heron D, Sanlaville D, Frebourg T, Muller J, Duffourd Y, Boland A, Deleuze JF, Espérou H, Binquet C, Dollfus H

Front Genet. 2022 ;13:852472

Care management in a French cohort with down syndrome from the AnDDI-Rares/CNSA study.

Roux-Levy PH, Sanlaville D, De Freminville B, Touraine R, Masurel A, Gueneau I, Cotinaud-Ricou A, Chancenotte S, Debomy F, Minot D, Bournez M, Rousseau I, Daniel S, Gautier E, Lacombe D, Taupiac E, Odent S, Mikaty M, Manouvrier S, Ghoumid J, Geneviève D, Lehman N, Busa T, Edery CP, Cornaton J, Gallard J, Héron D, Rastel C, Thauvin-Robinet C, Verloes A, Binquet C, Faivre L, Lejeune C

Eur J Med Genet. 2021 Jul 15;:104290

Cost-effectiveness analysis of resorbable biosynthetic mesh in contaminated ventral hernia repair.

Charleux-Muller D, Romain B, Boisson C, Velten M, Brigand C, Lejeune C

J Visc Surg. 2021 Jun 8;:

Incidental findings in a series of 2500 gene panel tests for a genetic predisposition to cancer: Results and Impact on patients.

Nambot S, Bertolone G, Sawka C, Cosset E, Goussot V, Derangère V, Boidot R, Baurand A, Robert M, Coutant C, Loustalot C, Thauvin-Robinet C, Ghiringhelli F, Lançon A, Populaire C, Damette A, Collonge-Rame MA, Meunier-Beillard N, Lejeune C, Albuisson J, Faivre L

Eur J Med Genet. 2021 Mar 19;:104196

Valuing genetic and genomic testing in France: current challenges and latest evidence.

Lejeune C, Amado IF,

J Community Genet. 2021 Jan 16;:

Genome Sequencing for Genetics Diagnosis of Patients With Intellectual Disability: The DEFIDIAG Study.

Binquet C, Lejeune C, Faivre L, Bouctot M, Asensio ML, Simon A, Deleuze JF, Boland A, Guillemin F, Seror V, Delmas C, Espérou H, Duffourd Y, Lyonnet S, Odent S, Heron D, Sanlaville D, Frebourg T, Gerard B, Dollfus H

Front Genet. 2021 ;12:766964

Associations between cognitive performance and the rehabilitation, medical care and social support provided to French children with Prader-Willi syndrome.

Roux-Levy PH, Bournez M, Masurel A, Jean N, Chancenotte S, Bordes M, Debomy F, Minot D, Schmitt E, Vinault S, Gautier E, Lacombe D, Odent S, Mikaty M, Manouvrier S, Ghoumid J, Geneviève D, Lehman N, Philip N, Edery P, Cornaton J, Gallard J, Héron D, Rastel C, Huet F, Thauvin-Robinet C, Verloes A, Binquet C, Tauber M, Lejeune C, Faivre L

Eur J Med Genet. 2020 Sep 27;:104064

Efficiency of telemedicine for acute stroke: a cost-effectiveness analysis from a French pilot study.

Wallut L, Peyron C, Hervieu-Bègue M, Osseby GV, Giroud M, Legris N, Quantin C, Béjot Y, Lejeune C

Int J Technol Assess Health Care. 2020 Mar 2;:1-7

The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis.

Binquet C, Lejeune C, Seror V, Peyron F, Bertaux AC, Scemama O, Quantin C, Béjean S, Stillwaggon E, Wallon M

PLoS ONE. 2019 ;14(9):e0221709

Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.

Delanne J, Nambot S, Chassagne A, Putois O, Pelissier A, Peyron C, Gautier E, Thevenon J, Cretin E, Bruel AL, Goussot V, Ghiringhelli F, Boidot R, Tran-Mau-Them F, Philippe C, Vitobello A, Demougeot L, Vernin C, Lapointe AS, Bardou M, Luu M, Binquet C, Lejeune C, Joly L, Juif C, Baurand A, Sawka C, Bertolone G, Duffourd Y, Sanlaville D, Pujol P, Geneviève D, Houdayer F, Thauvin-Robinet C, Faivre L

Eur J Med Genet. 2018 Aug 27;:

Identification of resources and skills developed by partners of patients with advanced colon cancer: a qualitative study.

Meunier-Beillard N, Ponthier N, Lepage C, Gagnaire A, Gheringuelli F, Bengrine L, Boudrant A, Rambach L, Quipourt V, Devilliers H, Lejeune C

Support Care Cancer. 2018 Jun 5;:

[Economic analysis of multinational clinical trials in oncology].

Lejeune C, Lueza B, Bonastre J,

Bull Cancer. 2018 Feb;105(2):204-211

Cost-effectiveness of diagnostic tests for threatened preterm labor in singleton pregnancy in France.

Desplanches T, Lejeune C, Cottenet J, Sagot P, Quantin C

Cost Eff Resour Alloc. 2018 ;16:21

Incidence of solitary pulmonary nodules in Northeastern France: a population-based study in five regions.

Marrer É, Jolly D, Arveux P, Lejeune C, Woronoff-Lemsi MC, Jégu J, Guillemin F, Velten M

BMC Cancer. 2017 Jan;17(1):47

Evaluation of efficacy and efficiency of a pragmatic intervention by a social worker to support informal caregivers of elderly patients (The ICE Study): study protocol for a randomized controlled trial.

Pozet A, Lejeune C, Bonnet M, Dabakuyo S, Dion M, Fagnoni P, Gaimard M, Imbert G, Nerich V, Foubert A, Chotard M, Bonin M, Anota A, Bonnetain F

Trials. 2016 Nov;17(1):531

[Pregnancy and substance use in France: a literature review].

Dumas A, Simmat-Durand L, Lejeune C

J Gynecol Obstet Biol Reprod (Paris). 2014 Nov;43(9):649-56

Economic analysis of the costs associated with prematurity from a literature review.

Soilly AL, Lejeune C, Quantin C, Bejean S, Gouyon JB

Public Health. 2014 Jan;128(1):43-62

The cost-effectiveness of immunochemical tests for colorectal cancer screening.

Lejeune C, Le Gleut K, Cottet V, Galimard C, Durand G, Dancourt V, Faivre J

Dig Liver Dis. 2014 Jan;46(1):76-81

Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.

Hamza S, Dancourt V, Lejeune C, Bidan JM, Lepage C, Faivre J

Eur J Cancer. 2013 Aug;49(12):2727-33

[Prostate cancer: how do patients choose their treatment?].

Enel C, Matte A, Berchi C, Binquet C, Cormier L, Lejeune C

Bull Cancer. 2013 Mar;100(3):191-9

Screening for colorectal cancer with immunochemical faecal occult blood tests.

Faivre J, Dancourt V, Lejeune C

Dig Liver Dis. 2012 Dec;44(12):967-73

Fractions of cardiovascular diseases, mental disorders, and musculoskeletal disorders attributable to job strain.

Sultan-Taieb H, Lejeune C, Drummond A, Niedhammer I

Int Arch Occup Environ Health. 2011 Dec;84(8):911-25

Cost of pretherapeutic staging of patients with colorectal cancer metastases in a French population.

Lejeune C, Loge P, Arveux P, Velten M, Jolly D, Woronoff-Lemsi MC, Guillemin F

Clin Res Hepatol Gastroenterol. 2011 May;35(5):399-407

Socio-economic disparities in access to treatment and their impact on colorectal cancer survival.

Lejeune C, Sassi F, Ellis L, Godward S, Mak V, Day M, Rachet B

Int J Epidemiol. 2010 Jun;39(3):710-7

Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test.

Lejeune C, Dancourt V, Arveux P, Bonithon-Kopp C, Faivre J

Int J Technol Assess Health Care. 2010 Jan;26(1):40-7.

Estimating the cost related to surveillance of colorectal cancer in a French population.

Lejeune C, Binquet C, Bonnetain F, Mahboubi A, Abrahamowicz M, Moreau T, Raikou M, Bedenne L, Quantin C, Bonithon-Kopp C

Eur J Health Econ. 2009 Oct;10(4):409-19

[Conducting a cost-effectiveness trial in oncology: justification and method]

Lejeune C, Binquet C, Bonnetain F

Bull Cancer. 2009 May;96(5):603-7

Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France.

Lemonnier I, Baumann C, Jay N, Alzahouri K, Arveux P, Jolly D, Lejeune C, Velten M, Vitry F, Woronoff-Lemsi MC, Guillemin F

BMC Cancer. 2009 May 11;9:139.

Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France.

Clerc L, Jooste V, Lejeune C, Schmitt B, Arveux P, Quantin C, Faivre J, Bouvier AM

Eur J Health Econ. 2008 Nov;9(4):361-7

Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.

Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J

Eur J Cancer. 2008 Oct;44(15):2254-8

[Initial management of gynecologic cancers: reference guides of the Societe Francaise d'Oncologie Gynecologique (SFOG) ]

Querleu D, Bonnier P, Morice P, Narducci F, Lhomme C, Haie-Meder C, Aubard Y, Baldauf JJ, Barillot I, Castelain B, Cuisenier J, Duvillard P, Genestie C, Houvenaeghel G, Leblanc E, Lefranc JP, Lejeune C, Mathevet P, Pautier P, Romestaing P, Tubiana N, Villet R

Gynecol Obstet Fertil. 2008 Mar;36(3):338-52.